Renal Denervation in the Real World – Practical Guidance for New Users: On-demand

Published: 25 April 2022

  • Views:

    Views Icon 4633
  • Likes:

    Heart Icon 7
  • episode_image
    18m 9s
    Part 4 Discussion and Close
    Roland E Schmieder, Michel Burnier, Cara East, Konstantinos Tsioufis
Average (ratings)
No ratings
Your rating

Overview

In this on-demand version of the live broadcast, Radcliffe Medical Education brings together a globally-renowned European and American faculty to share best practices on resistant hypertension and renal denervation (RDN).

 

This programme has been carefully curated for healthcare professionals that manage patients with resistant hypertension. This expert guidance will distil the most important practical points on identifying candidates for RDN. The programme aims to draw attention to the current scale of resistant hypertension in the hypertensive population and impart understanding on appropriate patient selection for RDN.

 

Prof Roland Schmieder (University Hospital Erlangen, DE) moderates proceedings, and is joined by Prof Michel Burnier (University Hospital of Lausanne, CH), Prof Cara East (Texas A&M College of Medicine, US) and Prof Konstantinos Tsioufis (University of Athens, GR) for a series of insightful presentations and discussions.

This programme is supported by an unrestricted educational grant from Medtronic.

LEARNING OBJECTIVES

  • Assess the current global burden of resistant hypertension
  • Carry out appropriate assessments to identify resistant hypertension
  • Identify patients most likely to benefit from RDN
  • Recall the practical considerations for adopting RDN into routine practice
  • Recall the latest data on RDN from recent clinical trials

AUDIENCE

  • Interventionalists
  • Nephrologists
  • Specialists engaged in treating hypertension
  • General Practitioners
  • General Cardiologists

More from this programme

Part 1

Introduction and What Is the Place of RDN Today? 

Part 2

Practice-based Principles For the Future Use of Renal Denervation

Part 3

What Can Be Expected on RDN in the Future?

Part 4

Discussion and Close

Faculty Biographies

Roland E Schmieder

Roland E Schmieder

Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension

Roland E Schmieder is a Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension at the University Hospital Erlangen, Germany. He also directs the Institute of Preventative Medicine at the University Erlangen-Nuremberg and the Community Hospital Nuremberg. Roland is a member of numerous professional societies and committees, and is a Fellow of the American College of Physicians (ACP) and the American College of Cardiology (ACC). He is on the international Editorial Board of the American Journal of Hypertension, the Journal of Human Hypertension and the Journal of Nephrology, among other scientific journals. Professor Schmieder received his post-graduate medical training in nephrology, cardiology and hypertension at the University Hospital of Bonn, and then at the Alton Ochsner Foundation, New Orleans. He graduated in medicine from the…

View full profile
Konstantinos Tsioufis

Konstantinos Tsioufis

Professor of Cardiology,National and Kapodistrian University of Athens, Hippokration Hospital, Greece

Konstantinos Tsioufis is Professor of Cardiology and Director of 1st Cardiological Department, National and Kapodistrian University of Athens, Hippokration Hospital, Greece. Prof Tsioufis works as an interventional Cardiologist as well as Hypertension Specialist and he was a post-doctoral fellow at the Veterans Affairs Medical Centre, Georgetown University Washington DC, US. Professor Tsioufis’s research focuses on the hypertensive disease, atherosclerotic cardiovascular disease and interventional cardiology. 

View full profile